SG11202011378WA - Synthesis of tipifarnib - Google Patents

Synthesis of tipifarnib

Info

Publication number
SG11202011378WA
SG11202011378WA SG11202011378WA SG11202011378WA SG11202011378WA SG 11202011378W A SG11202011378W A SG 11202011378WA SG 11202011378W A SG11202011378W A SG 11202011378WA SG 11202011378W A SG11202011378W A SG 11202011378WA SG 11202011378W A SG11202011378W A SG 11202011378WA
Authority
SG
Singapore
Prior art keywords
tipifarnib
synthesis
Prior art date
Application number
SG11202011378WA
Other languages
English (en)
Inventor
Pingda Ren
Xiaohu Deng
Wanping Mai
Original Assignee
Kura Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kura Oncology Inc filed Critical Kura Oncology Inc
Publication of SG11202011378WA publication Critical patent/SG11202011378WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SG11202011378WA 2018-05-18 2019-05-17 Synthesis of tipifarnib SG11202011378WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862673693P 2018-05-18 2018-05-18
PCT/US2019/032765 WO2019222565A1 (en) 2018-05-18 2019-05-17 Synthesis of tipifarnib

Publications (1)

Publication Number Publication Date
SG11202011378WA true SG11202011378WA (en) 2020-12-30

Family

ID=66770583

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202011378WA SG11202011378WA (en) 2018-05-18 2019-05-17 Synthesis of tipifarnib

Country Status (13)

Country Link
US (1) US11542244B2 (https=)
EP (1) EP3793966A1 (https=)
JP (1) JP2021526513A (https=)
KR (1) KR20210039987A (https=)
CN (1) CN112424149B (https=)
AU (1) AU2019270163A1 (https=)
BR (1) BR112020023559A2 (https=)
CA (1) CA3100706A1 (https=)
EA (1) EA202092787A1 (https=)
MX (1) MX2020012305A (https=)
PH (1) PH12020551956A1 (https=)
SG (1) SG11202011378WA (https=)
WO (1) WO2019222565A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102839264B1 (ko) 2023-03-07 2025-07-29 단국대학교 천안캠퍼스 산학협력단 티피파르닙을 유효성분으로 포함하는 근감소증 예방 또는 치료용 약학 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214695T1 (de) 1994-09-23 2002-04-15 Darwin Discovery Ltd Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE69620445T2 (de) 1995-12-08 2002-12-12 Janssen Pharmaceutica N.V., Beerse (imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
BRPI0208075B8 (pt) * 2001-03-12 2021-05-25 Janssen Pharmaceutica Nv processo para a preparação de compostos de imidazol
DE602005007604D1 (de) * 2004-05-03 2008-07-31 Janssen Pharmaceutica Nv Diastereoselektive addition von lithiiertem n-methylimidazol an sulfinimine
JP5008554B2 (ja) * 2004-05-03 2012-08-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ イミダゾール化合物の製造用のジアステレオ選択的合成方法
CN100567291C (zh) * 2004-05-03 2009-12-09 詹森药业有限公司 用6-溴-4-(3-氯苯基)-2-甲氧基喹啉进行的非对映选择性合成方法
EP3221311B1 (en) * 2014-11-21 2019-10-30 Merck Patent GmbH Method for the production of praziquantel
CN104876856B (zh) 2015-05-05 2017-11-21 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑3‑氨基哌啶二盐酸盐的方法

Also Published As

Publication number Publication date
JP2021526513A (ja) 2021-10-07
PH12020551956A1 (en) 2021-08-16
CA3100706A1 (en) 2019-11-21
US20210246114A1 (en) 2021-08-12
EA202092787A1 (ru) 2021-02-09
MX2020012305A (es) 2021-03-25
KR20210039987A (ko) 2021-04-12
AU2019270163A1 (en) 2020-12-03
CN112424149A (zh) 2021-02-26
CN112424149B (zh) 2023-06-23
EP3793966A1 (en) 2021-03-24
US11542244B2 (en) 2023-01-03
WO2019222565A1 (en) 2019-11-21
BR112020023559A2 (pt) 2021-02-09

Similar Documents

Publication Publication Date Title
HUE061482T2 (hu) Szintézismódszer
IL279468A (en) Crystallographic modifications of odeviccibat
PL3645518T3 (pl) Synteza omekamtywu mekarbilu
IL282701B2 (en) Methods for the synthesis of a radionuclide complex
HUE068098T2 (hu) Eljárás eliglusztát és köztitermékei elõállítására
GB201806072D0 (en) Methods of manufacture
IL273784A (en) Synthesis of cantharidin
HUE066451T2 (hu) Mezotrion szintézise
PL3845521T3 (pl) Sposoby syntezy upadacytynibu i jego produktów pośrednich
IL291221A (en) Methods for the synthesis of wolbenzine
IL279365A (en) Synthesis of coelantrazine
GB201805904D0 (en) Methods of Manufacture
GB201710241D0 (en) New route of synthesis for opicapone
IL276107A (en) Crystalline forms of psoorstam
SG11202011378WA (en) Synthesis of tipifarnib
GB201903055D0 (en) Method of oligonucleaotide synthesis
GB201817932D0 (en) Peptide synthesis
GB201804905D0 (en) Cataltic synthesis of biarylic compounds
PL3966214T3 (pl) Synteza koelenterazyny
SG11202105136WA (en) Application of chidamide
PT3759082T (pt) Processo para a síntese de 6-clorometiluracilo
SG11202101817UA (en) Methods of inhibition
PT3713939T (pt) Processo melhorado para a síntese de fármaco ligante vcseco- duba
HK40041245A (en) Synthesis of tipifarnib
GB201917499D0 (en) Methods of synthesis